233 related articles for article (PubMed ID: 14691452)
1. Abnormal production of the TNF-homologue APRIL increases the proliferation of human malignant glioblastoma cell lines via a specific receptor.
Deshayes F; Laprée G; Portier A; Richard Y; Pencalet P; Mahieu-Caputo D; Horellou P; Tsapis A
Oncogene; 2004 Apr; 23(17):3005-12. PubMed ID: 14691452
[TBL] [Abstract][Full Text] [Related]
2. Identification of proteoglycans as the APRIL-specific binding partners.
Ingold K; Zumsteg A; Tardivel A; Huard B; Steiner QG; Cachero TG; Qiang F; Gorelik L; Kalled SL; Acha-Orbea H; Rennert PD; Tschopp J; Schneider P
J Exp Med; 2005 May; 201(9):1375-83. PubMed ID: 15851487
[TBL] [Abstract][Full Text] [Related]
3. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A
Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217
[TBL] [Abstract][Full Text] [Related]
4. The uncertain glory of APRIL.
Medema JP; Planelles-Carazo L; Hardenberg G; Hahne M
Cell Death Differ; 2003 Oct; 10(10):1121-5. PubMed ID: 14502235
[TBL] [Abstract][Full Text] [Related]
5. Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development.
Alexaki VI; Notas G; Pelekanou V; Kampa M; Valkanou M; Theodoropoulos P; Stathopoulos EN; Tsapis A; Castanas E
J Immunol; 2009 Nov; 183(9):5948-56. PubMed ID: 19828625
[TBL] [Abstract][Full Text] [Related]
6. The BAFF/APRIL system: life beyond B lymphocytes.
Ng LG; Mackay CR; Mackay F
Mol Immunol; 2005 May; 42(7):763-72. PubMed ID: 15829264
[TBL] [Abstract][Full Text] [Related]
7. Novel function of TNF cytokines in regulating bone marrow B cell survival.
Zhang M; Ko KH; Lam QL; Lo CK; Xu DJ; Shen L; Zheng B; Srivastava G; Lu L
Cell Mol Immunol; 2004 Dec; 1(6):447-53. PubMed ID: 16293214
[TBL] [Abstract][Full Text] [Related]
8. APRIL and BAFF proteins increase proliferation of human adipose-derived stem cells through activation of Erk1/2 MAP kinase.
Zonca M; Mancheño-Corvo P; DelaRosa O; Mañes S; Büscher D; Lombardo E; Planelles L
Tissue Eng Part A; 2012 Apr; 18(7-8):852-9. PubMed ID: 22059379
[TBL] [Abstract][Full Text] [Related]
9. Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation.
Hendriks J; Planelles L; de Jong-Odding J; Hardenberg G; Pals ST; Hahne M; Spaargaren M; Medema JP
Cell Death Differ; 2005 Jun; 12(6):637-48. PubMed ID: 15846369
[TBL] [Abstract][Full Text] [Related]
10. [Antiproliferative effect of tumor necrosis factor-alpha on human glioblastoma cells].
Kato T
Hokkaido Igaku Zasshi; 1995 Mar; 70(2):261-74. PubMed ID: 7774879
[TBL] [Abstract][Full Text] [Related]
11. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF.
Thompson JS; Bixler SA; Qian F; Vora K; Scott ML; Cachero TG; Hession C; Schneider P; Sizing ID; Mullen C; Strauch K; Zafari M; Benjamin CD; Tschopp J; Browning JL; Ambrose C
Science; 2001 Sep; 293(5537):2108-11. PubMed ID: 11509692
[TBL] [Abstract][Full Text] [Related]
12. Identification of downstream genes up-regulated by the tumor necrosis factor family member TALL-1.
Xu LG; Wu M; Hu J; Zhai Z; Shu HB
J Leukoc Biol; 2002 Aug; 72(2):410-6. PubMed ID: 12149433
[TBL] [Abstract][Full Text] [Related]
13. B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses.
Xu S; Lam KP
Mol Cell Biol; 2001 Jun; 21(12):4067-74. PubMed ID: 11359913
[TBL] [Abstract][Full Text] [Related]
14. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease.
Gross JA; Johnston J; Mudri S; Enselman R; Dillon SR; Madden K; Xu W; Parrish-Novak J; Foster D; Lofton-Day C; Moore M; Littau A; Grossman A; Haugen H; Foley K; Blumberg H; Harrison K; Kindsvogel W; Clegg CH
Nature; 2000 Apr; 404(6781):995-9. PubMed ID: 10801128
[TBL] [Abstract][Full Text] [Related]
15. APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop.
Moreaux J; Sprynski AC; Dillon SR; Mahtouk K; Jourdan M; Ythier A; Moine P; Robert N; Jourdan E; Rossi JF; Klein B
Eur J Haematol; 2009 Aug; 83(2):119-29. PubMed ID: 19456850
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis of common variable immunodeficiency.
Castigli E; Geha RS
J Allergy Clin Immunol; 2006 Apr; 117(4):740-6; quiz 747. PubMed ID: 16630927
[TBL] [Abstract][Full Text] [Related]
17. Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion.
Katsenelson N; Kanswal S; Puig M; Mostowski H; Verthelyi D; Akkoyunlu M
Eur J Immunol; 2007 Jul; 37(7):1785-95. PubMed ID: 17557373
[TBL] [Abstract][Full Text] [Related]
18. The crystal structure of a proliferation-inducing ligand, APRIL.
Wallweber HJ; Compaan DM; Starovasnik MA; Hymowitz SG
J Mol Biol; 2004 Oct; 343(2):283-90. PubMed ID: 15451660
[TBL] [Abstract][Full Text] [Related]
19. A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth.
Rennert P; Schneider P; Cachero TG; Thompson J; Trabach L; Hertig S; Holler N; Qian F; Mullen C; Strauch K; Browning JL; Ambrose C; Tschopp J
J Exp Med; 2000 Dec; 192(11):1677-84. PubMed ID: 11104810
[TBL] [Abstract][Full Text] [Related]
20. BAFF costimulation of Toll-like receptor-activated B-1 cells.
Ng LG; Ng CH; Woehl B; Sutherland AP; Huo J; Xu S; Mackay F; Lam KP
Eur J Immunol; 2006 Jul; 36(7):1837-46. PubMed ID: 16791880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
